<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ali I</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>AmfAR Institute for HIV Cure Research</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>University of California, San Francisco</funding><funding>American Society for Microbiology</funding><funding>National Institute on Drug Abuse</funding><funding>NIGMS NIH HHS</funding><funding>National Institute on Aging</funding><pagination>1216-1252</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6609103</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(3)</volume><pubmed_abstract>Post-translational acetylation of lysine residues has emerged as a key regulatory mechanism in all eukaryotic organisms. Originally discovered in 1963 as a unique modification of histones, acetylation marks are now found on thousands of nonhistone proteins located in virtually every cellular compartment. Here we summarize key findings in the field of protein acetylation over the past 20 years with a focus on recent discoveries in nuclear, cytoplasmic, and mitochondrial compartments. Collectively, these findings have elevated protein acetylation as a major post-translational modification, underscoring its physiological relevance in gene regulation, cell signaling, metabolism, and disease.</pubmed_abstract><journal>Chemical reviews</journal><pubmed_title>Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.</pubmed_title><pmcid>PMC6609103</pmcid><funding_grant_id>R21 AG051111</funding_grant_id><funding_grant_id>P30 AI027763</funding_grant_id><funding_grant_id>1DP1DA038043</funding_grant_id><funding_grant_id>DP1 DA038043</funding_grant_id><funding_grant_id>T32 AI007334</funding_grant_id><funding_grant_id>R01 AI083139</funding_grant_id><funding_grant_id>R01 DA043142</funding_grant_id><funding_grant_id>R01DA043142</funding_grant_id><funding_grant_id>5R24 DK085610-06</funding_grant_id><funding_grant_id>T32 GM007175</funding_grant_id><funding_grant_id>R01AI083139-06</funding_grant_id><funding_grant_id>R24 DK085610</funding_grant_id><funding_grant_id>R21AG051111</funding_grant_id><pubmed_authors>Ali I</pubmed_authors><pubmed_authors>Conrad RJ</pubmed_authors><pubmed_authors>Ott M</pubmed_authors><pubmed_authors>Verdin E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.</name><description>Post-translational acetylation of lysine residues has emerged as a key regulatory mechanism in all eukaryotic organisms. Originally discovered in 1963 as a unique modification of histones, acetylation marks are now found on thousands of nonhistone proteins located in virtually every cellular compartment. Here we summarize key findings in the field of protein acetylation over the past 20 years with a focus on recent discoveries in nuclear, cytoplasmic, and mitochondrial compartments. Collectively, these findings have elevated protein acetylation as a major post-translational modification, underscoring its physiological relevance in gene regulation, cell signaling, metabolism, and disease.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Feb</publication><modification>2024-11-21T03:27:28.702Z</modification><creation>2019-07-25T07:03:46Z</creation></dates><accession>S-EPMC6609103</accession><cross_references><pubmed>29405707</pubmed><doi>10.1021/acs.chemrev.7b00181</doi></cross_references></HashMap>